NDC 67184-0531 – Gefitinib
Gefitinib 250 mg/1 · Tablet, Coated · Oral
Product NDC67184-0531
Product details
- Brand name
- Gefitinib
- Generic name
- Gefitinib
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- Tablet, Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA211591
- Marketed since
- February 13, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Gefitinib 250 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 67184-0531-1 | 30 TABLET, COATED in 1 BOTTLE (67184-0531-1) | Feb 13, 2023 |
| 67184-0531-2 | 500 TABLET, COATED in 1 BOTTLE (67184-0531-2) | Feb 13, 2023 |
| 67184-0531-3 | 3 BLISTER PACK in 1 CARTON (67184-0531-3) / 10 TABLET, COATED in 1 BLISTER PACK | Feb 13, 2023 |